Latest News and Press Releases
Want to stay updated on the latest news?
-
Highlights: Placement completed, with oversubscriptions accepted up to $13.9 MillionFidelity Investments follows on to maintain 10.6% ownership of the CompanyIFM Investors and Regal FM to become...
-
Medibio will leverage its proprietary Digital Mental Health platform to process Otsuka clinical data with the goal of further clarifying the role of biomarker-based, objective measures in management...
-
SYDNEY, Australia and MINNEAPOLIS, July 19, 2017 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a digital health company that has developed an objective testing...
-
SYDNEY, Australia and MINNEAPOLIS, July 05, 2017 (GLOBE NEWSWIRE) -- Australian Stock Exchange listed medical technology company Medibio Limited (MEB or the Company) is pleased to announce the...
-
Scientific breakthrough for non-invasive, automatic, objective diagnosis of PTSD leveraging autonomic biomarkersAccuracy of 80% (+/- 1%) for objectively diagnosing subjects with PTSDMedibio has...
-
호주 시드니, June 06, 2017 (GLOBE NEWSWIRE) -- 호주의 정신의학 전문기술업체인 메디바이오(Medibio Limited, ASX: MEB)가 역사상 최다메달수를 기록한 수영선수이자 정신건강부문 활동가인 마이클 펠프스를 자사 이사회 회원으로 임명했다고 오늘 발표했다. 메디바이오는 우울증, 만성 스트레스, 기타 정신건강질환 진단에...
-
SYDNEY, Australia, June 06, 2017 (GLOBE NEWSWIRE) -- Medibio Limited (ASX:MEB) (MEB atau Syarikat), iaitu sebuah syarikat teknologi perubatan yang tersenarai dalam ASX yang telah membangunkan ujian...
-
シドニー（オーストラリア）発, June 06, 2017 (GLOBE NEWSWIRE) -- 鬱病や慢性ストレス、その他の精神障害の診断に役立つ効果的な客観的テストを開発したメディバイオ･リミテッド（Medibio Limited、ASX:MEB、以下「メディバイオ」または「同社」）...
-
澳大利亚悉尼, June 06, 2017 (GLOBE NEWSWIRE) -- Medibio Limited (ASX:MEB)（以下简称 "MEB" 或“公司”）——一家在澳洲证券交易所上市的医疗科技公司，为帮助诊断抑郁症、慢性压力及其他的心理健康障碍开发了一套有效的客观测验——今天宣布任命史上获得最多荣誉的游泳运动员及心理健康倡导者为董事。自 2016...
-
SYDNEY, June 06, 2017 (GLOBE NEWSWIRE) -- Medibio Limited (ASX:MEB) (MEB หรือ บริษัทฯ) ซึ่งเป็นบริษัทด้านเทคนิคทางการแพทย์ที่จดทะเบียนในตลาดหลักทรัพย์ ASX...